Showing results (2891-2900 of 8,983) with videos related to
Sort By:
Pageof 899
Journal of Hepatology|March 29, 2000
Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosisJ Guéchot, L Serfaty, A M Bonnand, et al.Journal of Hepatology|March 29, 2000
Successful treatment of chronic Budd-Chiari syndrome with a transjugular intrahepatic portosystemic shuntP Michl, M Bilzer, T Waggershauser, et al.Journal of Hepatology|February 15, 2000
Enhanced monocyte activation and hepatotoxicity in response to endotoxin in portal hypertensionS Pérez del Pulgar, P Pizcueta, P Engel, et al.Journal of Hepatology|February 15, 2000
Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistanceH Kojima, J Yamao, T Tsujimoto, et al.Journal of Hepatology|February 15, 2000
Pericardial disease is often not recognised as a cause of chronic severe ascitesS Van der Merwe, J Dens, W Daenen, et al.Journal of Hepatology|December 22, 1999
Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesionsC Hézode, C Cazeneuve, O Coué, et al.Journal of Hepatology|December 22, 1999
Prevalence and clinical characteristics of TT virus (TTV) in patients with sporadic acute hepatitis of unknown etiologyM C Parquet, H Yatsuhashi, M Koga, et al.Journal of Hepatology|December 22, 1999
Inhibition of T cell activation by normal human biliary epithelial cellsS M Cruickshank, J Southgate, P J Selby, et al.Journal of Hepatology|December 22, 1999
Targeting of superoxide dismutase to the liver results in anti-inflammatory effects in rats with fibrotic liversP J Swart, T Hirano, M E Kuipers, et al.Journal of Hepatology|December 22, 1999
The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in ratsS Reif, B Weis, H Aeed, et al.Pageof 899